Paul Tudor Jones Tudor Investment Corp
Paul Tudor Jones is the founder of Tudor Investment Corporation and a pioneering macro trader. He rose to prominence after navigating the 1987 market crash successfully and has since built a multi-strategy firm spanning global markets. Jones is widely associated with discretionary macro trading, risk management discipline, and high-profile philanthropic efforts in education and the environment.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Russell 2000 ETF
IWM
|
+$662M |
| 2 |
Invesco QQQ Trust
QQQ
|
+$116M |
| 3 |
Broadcom
AVGO
|
+$96.2M |
| 4 |
Walmart Inc
WMT
|
+$91.2M |
| 5 |
ITCI
Intra-Cellular Therapies Inc.
ITCI
|
+$77.5M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Bitcoin Trust
IBIT
|
+$175M |
| 2 |
State Street Energy Select Sector SPDR ETF
XLE
|
+$152M |
| 3 |
iShares Core S&P 500 ETF
IVV
|
+$149M |
| 4 |
INFN
Infinera Corporation Common Stock
INFN
|
+$108M |
| 5 |
iShares MSCI Emerging Markets ETF
EEM
|
+$70.4M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 5.92% |
| 2 | Financials | 4.33% |
| 3 | Healthcare | 3.85% |
| 4 | Consumer Discretionary | 3.59% |
| 5 | Industrials | 3.49% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
426
Teva Pharmaceuticals
TEVA
$43.5B
| $10.7M | 0.04% |
697,457
+247,456
| +55% | +$4.42M |
|
427
CALL
W.W. Grainger
GWW
$61.8B
| $10.7M | 0.04% |
10,800
+1,400
| +15% | +$1.45M |
|
428
Ryder
R
$9.58B
| $10.7M | 0.04% |
74,137
+72,270
| +3,871% | +$11.3M |
|
429
Fluor
FLR
$7.01B
| $10.6M | 0.04% |
+296,872
| New | +$12.8M |
|
430
Cactus
WHD
$5.57B
| $10.6M | 0.04% |
231,602
-50,669
| -18% | -$2.81M |
|
431
PUT
Microchip Technology
MCHP
$41.3B
| $10.6M | 0.04% |
219,200
+88,300
| +67% | +$4.92M |
|
432
PUT
Deckers Outdoor
DECK
$12.5B
| $10.6M | 0.04% |
94,900
+93,800
| +8,527% | +$15.2M |
|
433
CoreCivic
CXW
$3.36B
| $10.6M | 0.04% |
521,809
+110,037
| +27% | +$2.21M |
|
434
DNOW Inc
DNOW
$2.83B
| $10.6M | 0.04% |
619,604
+424,122
| +217% | +$6.42M |
|
435
Sotera Health
SHC
$5.58B
| $10.6M | 0.04% |
907,430
+88,739
| +11% | +$1.14M |
|
436
National Grid
NGG
$80.2B
| $10.6M | 0.04% |
167,957
+86,143
| +105% | +$5.06M |
|
437
Cellebrite
CLBT
$2.77B
| $10.5M | 0.04% |
542,025
+5,903
| +1% | +$124K |
|
438
Alexandria Real Estate Equities
ARE
$9.21B
| $10.5M | 0.03% |
113,645
+26,928
| +31% | +$2.64M |
|
439
Unifirst Corp
UNF
$5.25B
| $10.5M | 0.03% |
60,180
+32,098
| +114% | +$6.7M |
|
|
SNV
440
DELISTED
Synovus
SNV
| $10.5M | 0.03% |
+223,829
| New | +$11.6M |
|
|
SWTX
441
DELISTED
SpringWorks Therapeutics
SWTX
| $10.4M | 0.03% |
+235,981
| New | +$10.9M |
|
442
Charles River Laboratories
CRL
$14.1B
| $10.4M | 0.03% |
69,125
+12,839
| +23% | +$2.15M |
|
443
PUT
Upstart Holdings
UPST
$2.95B
| $10.4M | 0.03% |
225,300
+219,300
| +3,655% | +$13.6M |
|
444
Viper Energy
VNOM
$16.3B
| $10.4M | 0.03% |
+229,373
| New | +$10.8M |
|
445
Jefferies Financial Group
JEF
$12.1B
| $10.3M | 0.03% |
+192,827
| New | +$13.1M |
|
446
CACI
CACI
$14.3B
| $10.3M | 0.03% |
28,125
+8,172
| +41% | +$3.13M |
|
447
Cloudflare
NET
$104B
| $10.3M | 0.03% |
+91,525
| New | +$12.1M |
|
448
State Street SPDR S&P Oil & Gas Exploration & Production ETF
XOP
$3.86B
| $10.3M | 0.03% |
78,003
+57,187
| +275% | +$7.67M |
|
449
Waste Management
WM
$89.6B
| $10.2M | 0.03% |
44,167
-142,319
| -76% | -$31.5M |
|
450
Badger Meter
BMI
$3.82B
| $10.2M | 0.03% |
53,610
-8,367
| -14% | -$1.75M |
|
Similar funds
Paul Tudor Jones's Q1 2025 Portfolio in Review
As of Q1 2025, Paul Tudor Jones held 3,818 positions worth $30.1B, up 15% from $26.3B the previous quarter. Its ten largest holdings account for 40% of the portfolio.
Paul Tudor Jones deployed $6.13B of net new capital in Q1 2025, opening 874 new positions and adding to 1,161 existing holdings. Its largest new stake was Intra-Cellular Therapies Inc.: 621,815 shares worth $82M.
By sector, the portfolio is most concentrated in Technology at 5.9% of assets, down from 6.4% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was iShares Bitcoin Trust, an estimated $175M trimmed.
- Paul Tudor Jones's largest Q1 2025 buy was Intra-Cellular Therapies Inc.: 621,815 shares worth $82M.
- Paul Tudor Jones added most to iShares Russell 2000 ETF in Q1 2025, an estimated $662M increase.
- Paul Tudor Jones's biggest Q1 2025 reduction was iShares Bitcoin Trust, cutting an estimated $175M.
- Paul Tudor Jones fully exited Infinera Corporation Common Stock in Q1 2025, selling an estimated $108M.
- Paul Tudor Jones's ten largest holdings make up 40% of its $30.1B portfolio in Q1 2025.
- Paul Tudor Jones opened 874 new positions and closed 844 in Q1 2025.
- Paul Tudor Jones's portfolio value rose 15% quarter-over-quarter to $30.1B.
Based on Tudor Investment Corp's 13F filing for Q1 2025, filed 15 May 2025.